Physician profile
Steven Stecker
NPI 1346335874
$7,249.04
in general payments reported to CMS, 2019-2025
24 companies · $2,028 in 2025
The $2,028 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $565 · 2020: $386 · 2021: $1,594 · 2022: $1,571 · 2023: $723 · 2024: $381 · 2025: $2,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,028 · Food and Beverage: $1,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,028.44 |
| Food and Beverage | $1,103.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $3,137.48 | 2021-2025 | |
| Arthrex, INC. | $1,054.90 | 2025 | |
| Zimmer Biomet Holdings, INC. | $740.26 | 2022-2025 | Rosa, Juggerknotless Soft Anchor |
| Stryker Corporation | $396.34 | 2019-2025 | T2 Alpha, Insignia, Pangea |
| Ferring Pharmaceuticals INC. | $374.63 | 2019-2025 | Euflexxa |
| Horizon Therapeutics Plc | $323.04 | 2019-2021 | |
| Depuy Synthes Sales INC. | $257.80 | 2019-2023 | Orthovisc |
| Bioventus LLC | $201.62 | 2019-2024 | Gelsyn-3, Durolane, Bonescalpel & Sonicone (O.R.) |
| Fidia Pharma USA INC. | $164.63 | 2019-2022 | |
| Smith+Nephew, INC. | $162.01 | 2020-2023 | Pico 14 |
| Sanofi-Aventis U.S. LLC | $62.34 | 2019-2022 | |
| Heraeus Medical, LLC. | $60.92 | 2024 | |
| Avanos Medical | $57.03 | 2024 | Trivisc Sodium Hyaluronate |
| Medacta USA, INC. | $39.29 | 2024-2025 | Nextar Shoulder |
| Kowa Pharmaceuticals America, INC. | $30.00 | 2022-2023 | Seglentis |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $26.92 | 2019 | |
| Orthofix Medical, INC. | $26.02 | 2025 | Physio-Stim |
| Ossur Americas, INC. | $24.85 | 2024 | Miami J |
| Orthogenrx INC. | $21.25 | 2020 | |
| Ethicon US, LLC | $20.31 | 2019 | |
| Medtronic, INC. | $17.63 | 2024 | Plasmablade(Tm) |
| Linkbio Corp | $17.39 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $17.29 | 2024 | |
| Pfizer INC. | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Stecker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.